VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IMA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IMAImageneBio Inc
$6.07$68M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIMAQuarterly Financials

ImageneBio Inc (IMA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ImageneBio Inc (IMA) quarterly income statement — complete revenue, gross profit & net income history

IMA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000659K1.19M2M5.31M5.45M6.4M382K3.38M20.22M3.75M3.55M
Revenue Growth %------100%-100%-100%-100%-87.91%-81.49%424.61%57%-73.04%70.9%-89.24%-2.59%31003.08%32.41%-
Cost of Goods Sold174K561K045K3.71M4.58M6.82M400K9.64M305K242K14.19M015.64M18.85M15.49M14.34M12.34M13.38M11.37M
COGS % of Revenue---------46.28%20.42%707.98%-286.95%294.44%4054.45%423.85%61.03%357.05%320.48%
Gross Profit-174K-561K0-45K-3.71M-4.58M-6.82M-400K-9.64M354K943K-12.18M5.31M-10.19M-12.45M-15.11M-10.96M7.88M-9.63M-7.83M
Gross Margin %---------53.72%79.58%-607.98%100%-186.95%-194.44%-3954.45%-323.85%38.97%-257.05%-220.48%
Gross Profit Growth %95.32%87.75%100%88.75%61.48%-1393.79%-823.01%96.72%-281.54%103.47%107.58%19.34%148.48%-229.32%-29.28%-93.05%-67.39%133.76%-119.39%-
Operating Expenses11.9M7.94M26.59M8.71M7.08M7.94M5.59M15.42M8.58M22.26M20.45M6.31M20.83M4.92M5.43M5.84M6M5.09M4.89M4.86M
OpEx % of Revenue---------3378.15%1725.4%314.67%392.02%90.37%84.79%1530.1%177.39%25.16%130.62%137%
Selling, General & Admin6.12M-370K11.04M4.42M5.64M7.59M4.78M5.31M6M8.29M6.03M5.32M5.28M4.92M5.43M5.84M6M5.09M4.89M4.86M
SG&A % of Revenue---------1258.42%509.2%265.57%99.3%90.37%84.79%1530.1%177.39%25.16%130.62%137%
Research & Development5.96M5.23M15.56M4.03M3.71M4.58M6.82M9.83M9.64M13.97M1.19M15.17M15.55M15.64M18.85M15.49M14.34M12.34M13.38M11.37M
R&D % of Revenue---------2119.73%100%757.09%292.72%286.95%294.44%4054.45%423.85%61.03%357.05%320.48%
Other Operating Expenses-174K1000K0264K-1000K-1000K-1000K283K-1000K01000K-1000K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-12.08M-8.5M-26.59M-8.75M-10.79M-12.52M-12.41M-15.82M-18.23M-21.91M-19.5M-18.49M-15.52M-15.11M-17.88M-20.95M-16.96M2.79M-14.52M-12.69M
Operating Margin %----------3324.43%-1645.82%-922.65%-292.02%-277.32%-279.23%-5484.56%-501.24%13.81%-387.67%-357.48%
Operating Income Growth %-11.9%32.06%-114.35%44.7%40.78%42.87%36.38%14.42%-17.47%-44.95%-9.1%11.75%8.53%-641.33%-23.1%-65.14%-74.51%110.72%-132.99%-
EBITDA-12.08M-7.94M-24.76M-8.66M-10.71M-12.43M-12.32M-15.73M-18.01M-21.6M-19.26M-18.25M-15.28M-14.9M-17.66M-20.8M-16.78M2.96M-14.38M-12.54M
EBITDA Margin %----------3278.15%-1625.4%-910.58%-287.67%-273.47%-275.9%-5445.81%-495.92%14.62%-383.74%-353.4%
EBITDA Growth %-12.81%36.09%-101%44.93%40.54%42.47%36.05%13.79%-17.82%-44.95%-9.05%12.28%8.93%-604.37%-22.87%-65.87%-74.25%111.38%-133.44%-
D&A (Non-Cash Add-back)0561K087K87K89K90K92K219K305K242K242K231K210K213K148K180K163K147K145K
EBIT-12.08M-8.5M-24.76M-8.44M-9.36M-12.18M-11.6M-15.14M-15.64M-21.91M-19.5M-18.49M-15.52M-15.11M-17.88M-20.95M-16.96M2.79M-14.52M-12.69M
Net Interest Income1.13M2.44M1.1M1.29M1.42M1.57M1.77M1.92M2.11M975K2.16M0730K893K576K507K172K07K6K
Interest Income1.13M2.44M1.2M1.29M1.42M1.57M1.77M1.92M2.11M2.27M2.16M0730K893K576K507K172K07K6K
Interest Expense0096K0000001.3M0000000000
Other Income/Expense1.47M1.32M1.74M6M2.2M3.45M2.18M2.15M2.11M2.26M2.16M1.38M1.3M1.02M538K460K123K5K7K6K
Pretax Income-10.61M-7.18M-24.85M-2.75M-8.59M-9.07M-10.22M-13.67M-16.12M-19.65M-17.34M-17.11M-14.22M-14.1M-17.34M-20.49M-16.84M2.8M-14.52M-12.68M
Pretax Margin %----------2981.94%-1463.54%-854.04%-267.63%-258.66%-270.82%-5364.14%-497.61%13.83%-387.48%-357.31%
Income Tax10K-276K-74K15K28K53K10K62K27K-162K0000000000
Effective Tax Rate %-0.09%3.84%0.3%-0.55%-0.33%-0.58%-0.1%-0.45%-0.17%0.82%0%0%0%0%0%0%0%0%0%0%
Net Income-10.62M-6.91M-24.78M-2.77M-8.62M-9.12M-10.23M-13.73M-16.15M-19.49M-17.34M-17.11M-14.22M-14.1M-17.34M-20.49M-16.84M2.8M-14.52M-12.68M
Net Margin %----------2957.36%-1463.54%-854.04%-267.63%-258.66%-270.82%-5364.14%-497.61%13.83%-387.48%-357.31%
Net Income Growth %-23.2%24.29%-142.12%79.85%46.62%53.18%40.99%19.78%-13.55%-38.25%-0.03%16.48%15.56%-604%-19.45%-61.59%-73.31%110.74%-133.29%-
Net Income (Continuing)-10.62M-6.91M-24.78M-2.77M-8.62M-9.12M-10.23M-13.73M-16.15M-19.49M-17.34M-17.11M-14.22M-14.1M-17.34M-20.49M-16.84M2.8M-14.52M-12.68M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.95-0.62-3.01-0.06-0.18-0.19-0.21-0.28-0.33-0.41-0.40-0.43-0.39-0.36-0.46-0.55-0.460.08-0.40-0.35
EPS Growth %-427.78%-226.32%-1333.33%79.54%45.45%53.66%47.5%34.88%15.38%-13.89%13.04%21.82%15.22%-561.54%-15%-57.14%-17.95%104.19%9.09%-
EPS (Basic)-0.95-0.62-3.01-0.06-0.18-0.19-0.21-0.28-0.33-0.41-0.40-0.43-0.39-0.36-0.46-0.55-0.460.08-0.40-0.35
Diluted Shares Outstanding11.21M11.18M8.53M48.26M48.26M48.26M48.26M48.26M48.26M47.81M43.44M43.44M36.26M36.26M36.26M36.16M36.08M35.86M35.86M35.85M
Basic Shares Outstanding11.21M11.18M8.53M48.26M48.26M48.26M48.26M48.26M48.26M47.81M43.44M43.44M36.26M36.26M36.26M36.16M36.08M35.86M35.86M35.85M
Dividend Payout Ratio--------------------